文献速递慢性静脉疾病

氰基丙烯酸酯、射频与腔内激光消融对活动性静脉性溃疡愈合的当代比较

A Contemporary Comparison of Cyanoacrylate, Radiofrequency, and Endovenous Laser Ablation on Healing of Active Venous Ulceration.
PubMed 文献 · Ann Vasc Surg · 2022-04-23

单中心回顾性研究纳入2010至2020年146例接受氰基丙烯酸酯、射频或腔内激光消融的活动性静脉性溃疡患者,三种消融方式在溃疡愈合天数、复发率及术后深静脉血栓方面差异均无统计学意义;依从压力治疗与溃疡愈合时间缩短相关,而与伤口门诊合作者愈合时间显著更长。

要点

  • 三种消融方式在活动性静脉性溃疡愈合天数上差异无统计学意义。
  • 依从压力治疗与溃疡愈合时间缩短相关(HR 2.12,95%CI 1.10-4.20,P=0.031)。
  • 未与伤口门诊合作与溃疡愈合时间显著更长相关(HR 0.50,95%CI 0.33-0.75,P=0.001)。

核心结论

  • 本研究提示,在活动性静脉性溃疡患者中,与其他消融方式相比,氰基丙烯酸酯消融有愈合时间更长和并发症更多的趋势。
  • 依从压力治疗可预测静脉性溃疡愈合,而与伤口门诊合作者愈合时间显著更长。

研究设计与样本

  • 单中心、三级转诊中心的回顾性数据收集,纳入2010至2020年146例接受消融治疗的活动性静脉性溃疡患者。
  • 消融方式包括氰基丙烯酸酯(VenaSeal)、射频消融(RFA)和腔内激光消融(EVLA)。

主要发现

  • 干预后溃疡愈合天数:氰基丙烯酸酯消融80.8天(n=15),RFA 70.07天(n=44),EVLA 67.04天(n=79),差异无统计学意义。
  • 溃疡复发率:氰基丙烯酸酯消融35.7%(5/14),EVLA 26.7%(20/75),RFA 23.1%(9/39),差异无统计学意义。
  • 术后深静脉血栓发生率:氰基丙烯酸酯消融6.3%(1/16),EVLA 4.8%(4/84),RFA 2.2%(1/46),差异无统计学意义。
  • 静脉内胶所致血栓发生率氰基丙烯酸酯为6.3%,高于EVLA的静脉内热所致血栓3.6%和RFA的2.2%。
  • Cox比例风险分析显示,依从压力治疗(HR 2.12,95%CI 1.10-4.20,P=0.031)和未与伤口门诊合作(HR 0.50,95%CI 0.33-0.75,P=0.001)与溃疡愈合时间缩短相关,吸烟或糖尿病等其他合并症的存在未影响该结果。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The goal of this study is to compare the healing rates of active lower extremity venous ulcers for patients receiving one of 3 ablation methods, compare their complications, and identify factors affecting successful healing and prevention of recurrence. METHODS: For this study, data were collected retrospectively on 146 patients at a single institution, tertiary referral center, with an active venous ulcer who underwent ablation therapy via cyanoacrylate (VenaSeal), radiofrequency (RFA), or endovenous laser ablation (EVLA) from 2010 to 2020. RESULTS: The study showed a nonsignificant difference in days to ulcer healing postintervention between ablative techniques, with 80.8 days for cyanoacrylate ablation (n = 15), 70.07 for RFA (n = 44), and 67.04 days for EVLA (n = 79). A similar, nonsignificant trend was observed for ulcer recurrence, with a rate of 35.7% (5/14) for cyanoacrylate ablation, 26.7% (20/75) for EVLA, and 23.1% (9/39) for RFA. The same nonsignificant trend occurred with deep venous thrombosis following the procedure in 6.3% (1/16) of cyanoacrylate ablation, 4.8% (4/84) of EVLA, and 2.2% (1/46) of RFA cases. The rate of endovenous glue induced thrombosis was also higher (6.3%) for cyanoacrylate than endovenous heat induced thrombosis in EVLA (3.6%) and RFA (2.2%). Cox proportional hazard was significant for compliance with compression therapy (hazard ratio [HR] 2.12, confidence interval [CI] 95% = 1.10-4.20, P = 0.031) and a lack of working with a wound clinic (HR 0.50, CI 95% = 0.33-0.75, P = 0.001) were associated with the decreased time to healing of ulcer but was not influenced by the presence of other comorbidities of smoking or diabetes mellitus. CONCLUSIONS: This study indicates a trend toward cyanoacrylate ablation having longer healing times and more complications compared to other ablation methods when used in patients with active venous ulcers. Compliance with compression treatment is predictive of venous ulcer healing and working with a wound clinic had significantly longer healing times.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Korepta L, Ward M, Blecha M, et al. A Contemporary Comparison of Cyanoacrylate, Radiofrequency, and Endovenous Laser Ablation on Healing of Active Venous Ulceration. Ann Vasc Surg. 2022. PMID: 35472495. doi:10.1016/j.avsg.2022.04.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。